Epcoritamab Antibody
Epcoritamab is a bispecific antibody targeting CD3 and CD20, designed to engage T-cells for the elimination of malignant CD20-positive B-cells. It is utilized in preclinical and clinical research for relapsed/refractory B-cell lymphomas, including in vitro cytotoxicity assays and in vivo xenograft model studies.
Product Specifications
Product Name Alternative
Epcoritamab, GEN-3013, CD3
Target
Others, Integrin, Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
6.46 mg/mL
Purity
97.20% (May vary between batches)
Molecular Weight
145.89 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
